Avacta to Unveil Pipeline Expansion and Novel, Next-Generational Targeted Cancer Therapy Programs at 2024 EORTC-NCI-AACR Symposium ...

Primary target patient population for the CBX-12 Phase 2 study is women with platinum-resistant or refractory ovarian cancer who are naïve to ...

Photo: Jens Kalaene/dpa (Photo by Jens Kalaene/picture alliance via Getty Images) (NewsNation) — Weight-loss drugs, including the ones originally invented to treat Type 2 diabetes, have become victims ...

RGD peptides facilitate the self-assembly of stable nanostructures, ensuring efficient drug delivery. Despite their potential, challenges such as immunogenicity, stability, tumor heterogeneity, and ...

An curved arrow pointing right. Weight-loss drugs are everywhere, and food manufacturers are paying attention. Nestle just launched frozen meals tailored for people on weight-loss drugs like ...

FRIDAY, Sept. 27, 2024 (HealthDay News) -- The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and Drug Administration.

Antibody-drug conjugates (ADCs) represent a significant advancement in cancer treatment, particularly within China's burgeoning oncology sector. With a little over 100 ADC candidates in various stages ...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this ...

We’re losing the war on drugs. It’s not for any lack of vigilance by police on our borders or streets, where the powders, pills and chemical liquids are imported and sold. It’s just that Australia’s ...

Rothenhoefer had been testing a drug, sold by pharmaceutical company Eli Lilly, which later won FDA approval for weight loss in 2023 under the brand name Zepbound. A similar version of this drug ...